RxDoctor Payments Data

John Cummings

Psychiatric/Mental Health · Glendora, CANPI 1851924260

Payments from drug & device makers

$5,920in general payments, 2019–2025

Across 262 payments — averaging $22.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Vanda Pharmaceuticals Inc.$856
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$726
  • Alkermes, Inc.$706
  • Otsuka America Pharmaceutical, Inc.$612
  • Neurocrine Biosciences, Inc.$583
  • AbbVie$549
  • plus $2K from 10 others

What the payments were for

  • Food & beverage$5,85499%
  • Education$671%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,920 in reported general payments places this provider in the 90th percentile of 2,433 psychiatric/mental health providers in California.

See all psychiatric/mental health providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl46$87,044
RexultiBrexpiprazole30$34,953
TrintellixVortioxetine Hydrobromide21$14,858
Aripiprazole62$9,637
Ziprasidone Hcl35$4,551
Quetiapine Fumarate162$3,974
Mirtazapine143$3,193
Buspirone Hcl106$2,048
Divalproex Sodium49$1,908
Trazodone Hcl157$1,682
Duloxetine Hcl50$1,442
Benztropine Mesylate88$1,420
Olanzapine45$1,416
Escitalopram Oxalate117$1,408
Clonazepam151$1,368

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$549$87,04446 claims
Otsuka America Pharmaceutical, Inc.Rexulti$612$34,95330 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$45$14,85821 claims
Almatica Pharma LLCSertraline Hcl$85$75081 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,433 psychiatric/mental health providers in California.

Other psychiatric/mental health in Glendora

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →